These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1036951)

  • 21. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
    Diederich KW; Boyksen D
    Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
    [No Abstract]   [Full Text] [Related]  

  • 22. The antidysrhythmic aminosteroid, ORG 6001, reduces the ST-segment elevation produced by coronary occlusion in the dog.
    Marshall RJ; Parratt JR
    Br J Pharmacol; 1977 Oct; 61(2):315-7. PubMed ID: 922260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent on the cardiovascular and central nervous systems.
    Riley RL; Mir GN; Rowles GS; Sperow JW; Alioto RL; Yelnosky J
    Arzneimittelforschung; 1978; 28(8a):1461-6. PubMed ID: 582537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of an antispastic, analgesic combination on blood pressure, dynamics and contractility of the left ventricle in the dog].
    Komarek J
    Arzneimittelforschung; 1976; 26(8):1583-8. PubMed ID: 1036957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular effects of vasopressors in halothane-anesthetized dogs before and after hemorrhage.
    Curtis MB; Bednarski RM; Majors L
    Am J Vet Res; 1989 Nov; 50(11):1859-65. PubMed ID: 2619116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects].
    Femmer K; Grünheid K
    Pharmazie; 1976; 31(1):33-6. PubMed ID: 1257276
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
    Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
    Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of selected antiarrhythmic drugs on the hemodynamic parameters in rabbits during anesthesia. Part II. Thiopental anesthesia.
    Orszulak-Michalak D; Trzaskalska M
    Pol J Pharmacol; 1995; 47(2):153-62. PubMed ID: 8688888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of selected antiarrhythmic drugs on the hemodynamic parameters in rabbits during anesthesia. Part III. Ketamine anesthesia.
    Orszulak-Michalak D
    Pol J Pharmacol; 1995; 47(5):407-16. PubMed ID: 8868132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular function.
    Tuininga YS; Crijns HJ; Oosterhuis B; Wiesfeld AC; van Wijk LM; Albronda F; de Bruin H; Jonkman JH; Kozma C; Lie KI
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):408-14. PubMed ID: 7515984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of selected antiarrhythmic drugs on the hemodynamic parameters in rabbits during anesthesia. Part I. Propofol anesthesia.
    Orszulak-Michalak D
    Pol J Pharmacol; 1995; 47(2):143-52. PubMed ID: 8688887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
    Frederick LG; Hatley FR; McDonald SJ; Stamm MH; Garthwaite SM
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigations to characterize a new anti-arrhythmic drug, ORG 6001 including a simple test for calcium antagonism.
    Salako LA; Williams V; Wittig JH
    Br J Pharmacol; 1976 Jun; 57(2):251-62. PubMed ID: 7336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic effects of cibenzoline on normal myocardium and after pretreatment with DL-sotalol.
    Beyer ME; Hoffmeister HM; Seipel L
    J Cardiovasc Pharmacol; 1992 May; 19(5):657-64. PubMed ID: 1381761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
    Bergey JL; Sulkowski T; Much DR; Wendt RL
    Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of an aminosteroid, ORG 6001, on various membrane phenomena of non-myelinated nerve fibres of the rat.
    Kingma JH; Makken R; Hertog AD
    Eur J Pharmacol; 1978 May; 49(1):81-6. PubMed ID: 658128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiovascular and hemodynamic effects of derivatives of metoclopramide].
    Mouillé P; Cheymol G
    Arch Int Pharmacodyn Ther; 1975 May; 215(1):139-49. PubMed ID: 1156043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiovascular effect of a new antiarrhythmic drug--changrolin (author's transl)].
    Chen WZ; Dong YL; Ding GS
    Yao Xue Xue Bao; 1979 Dec; 14(12):710-4. PubMed ID: 554432
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hemodynamic effects of class-I and class-III anti-arrhythmia agents].
    Schmidt G; Honerjäger P; Niesel T
    Dtsch Med Wochenschr; 1989 Jun; 114(26):1040-5. PubMed ID: 2661189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.